FI106454B - Menetelmä 4-[4-[4-(hydroksidifenyylimetyyli)-1-piperidinyyli]-1-hydroksibutyyli]- ja 4-[4-[4-(hydroksidifenyylimetyyli)-1-piperidinyyli]-1-oksobutyyli]johdannaisten valmistamiseksi - Google Patents

Menetelmä 4-[4-[4-(hydroksidifenyylimetyyli)-1-piperidinyyli]-1-hydroksibutyyli]- ja 4-[4-[4-(hydroksidifenyylimetyyli)-1-piperidinyyli]-1-oksobutyyli]johdannaisten valmistamiseksi Download PDF

Info

Publication number
FI106454B
FI106454B FI944713A FI944713A FI106454B FI 106454 B FI106454 B FI 106454B FI 944713 A FI944713 A FI 944713A FI 944713 A FI944713 A FI 944713A FI 106454 B FI106454 B FI 106454B
Authority
FI
Finland
Prior art keywords
piperidinyl
hydroxydiphenylmethyl
oxobutyl
formula
acid
Prior art date
Application number
FI944713A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI944713A (fi
FI944713A0 (fi
Inventor
Michele Ann Kaminski
Chi-Hsin Richard King
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI944713A0 publication Critical patent/FI944713A0/fi
Publication of FI944713A publication Critical patent/FI944713A/fi
Application granted granted Critical
Publication of FI106454B publication Critical patent/FI106454B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI944713A 1992-04-10 1994-10-07 Menetelmä 4-[4-[4-(hydroksidifenyylimetyyli)-1-piperidinyyli]-1-hydroksibutyyli]- ja 4-[4-[4-(hydroksidifenyylimetyyli)-1-piperidinyyli]-1-oksobutyyli]johdannaisten valmistamiseksi FI106454B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US86726192A 1992-04-10 1992-04-10
US86726192 1992-04-10
US1725193A 1993-02-25 1993-02-25
US1725193 1993-02-25
PCT/US1993/002103 WO1993021156A1 (en) 1992-04-10 1993-03-10 4-diphenylmethyl piperidine derivatives and process for their preparation
US9302103 1993-03-10

Publications (3)

Publication Number Publication Date
FI944713A0 FI944713A0 (fi) 1994-10-07
FI944713A FI944713A (fi) 1994-12-02
FI106454B true FI106454B (fi) 2001-02-15

Family

ID=26689638

Family Applications (2)

Application Number Title Priority Date Filing Date
FI944713A FI106454B (fi) 1992-04-10 1994-10-07 Menetelmä 4-[4-[4-(hydroksidifenyylimetyyli)-1-piperidinyyli]-1-hydroksibutyyli]- ja 4-[4-[4-(hydroksidifenyylimetyyli)-1-piperidinyyli]-1-oksobutyyli]johdannaisten valmistamiseksi
FI20002460A FI20002460A (fi) 1992-04-10 2000-11-09 4-difenyylimetyylipiperidiinijohdannaisia

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI20002460A FI20002460A (fi) 1992-04-10 2000-11-09 4-difenyylimetyylipiperidiinijohdannaisia

Country Status (19)

Country Link
EP (1) EP0635004B1 (da)
JP (3) JP3686950B2 (da)
KR (1) KR100257805B1 (da)
AR (1) AR253777A1 (da)
AT (1) ATE220666T1 (da)
AU (1) AU671822B2 (da)
CA (1) CA2117892C (da)
DE (1) DE69332117T2 (da)
DK (1) DK0635004T3 (da)
ES (1) ES2176201T3 (da)
FI (2) FI106454B (da)
HU (1) HU226561B1 (da)
IL (1) IL105328A (da)
MX (1) MX9302076A (da)
NO (5) NO305076B1 (da)
NZ (1) NZ251132A (da)
PT (1) PT635004E (da)
TW (1) TW362096B (da)
WO (1) WO1993021156A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3041954B2 (ja) * 1992-08-03 2000-05-15 セプラコア インコーポレーテッド アレルギー疾患治療用のテルフェナジン代謝物及びその光学的に純粋な異性体
US20020007068A1 (en) 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
AU670004B2 (en) 1993-06-24 1996-06-27 Albany Molecular Research, Inc. Piperidine derivatives and process for their production
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
CA2362339C (en) * 1993-06-25 2005-08-02 Merrell Pharmaceuticals Inc. Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
DK0766668T3 (da) * 1994-05-18 2002-10-28 Aventis Pharma Inc Fremgangsmåde til fremstilling af vandfrie og hydratformer af som antihistaminer anvendelige piperidinderivater, polymorfer og pseudo-morfer deraf
AU701042B2 (en) 1995-02-28 1999-01-21 Aventisub Llc Pharmaceutical composition for piperidinoalkanol compounds
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6153754A (en) 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
KR100707904B1 (ko) * 1998-07-02 2007-04-16 아벤티스 파마슈티칼스 인크 항히스타민 피페리딘 유도체 및 이를 제조하기 위한 중간체
HUP0400299A2 (en) * 2001-04-09 2007-08-28 Teva Pharma Polymorphs of fexofenadine hydrochloride
ITRM20010260A1 (it) 2001-05-17 2002-11-18 Dinamite Dipharma S P A In For Processo per la preparazione della fexofenadina o acido 4 1-idrossi-4-4- (idrossidifenilmetil)-1-piperidinil|-butil|-alfa,alfa-dimetilbenz
US6743941B2 (en) 2001-06-15 2004-06-01 Aventis Pharma Deutschland Gmbh Process for the production of piperidine derivatives
JP2005532356A (ja) 2002-06-10 2005-10-27 テバ ファーマシューティカル インダストリーズ リミティド 塩酸フェキソフェナジンの多型体xvi
GB0319935D0 (en) 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
ITMI20070987A1 (it) 2007-05-16 2008-11-17 Dipharma Francis Srl Procedimento per la preparazione di composti chetonici
EP2289867A3 (en) 2009-08-19 2012-04-25 Jubilant Organosys Limited A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives

Also Published As

Publication number Publication date
WO1993021156A1 (en) 1993-10-28
NO305025B1 (no) 1999-03-22
NO981431D0 (no) 1998-03-30
TW362096B (en) 1999-06-21
AR253777A1 (es) 2001-10-08
NO943794L (no) 1994-12-09
FI944713A (fi) 1994-12-02
IL105328A (en) 2007-03-08
ATE220666T1 (de) 2002-08-15
DE69332117D1 (de) 2002-08-22
NO981433L (no) 1994-12-09
MX9302076A (es) 1994-03-31
FI944713A0 (fi) 1994-10-07
NO305076B1 (no) 1999-03-29
KR950700881A (ko) 1995-02-20
AU671822B2 (en) 1996-09-12
NZ251132A (en) 1996-12-20
NO305024B1 (no) 1999-03-22
NO981434D0 (no) 1998-03-30
CA2117892C (en) 2001-12-18
DE69332117T2 (de) 2003-01-30
NO943794D0 (no) 1994-10-07
CA2117892A1 (en) 1993-10-28
JPH08502022A (ja) 1996-03-05
KR100257805B1 (ko) 2000-07-01
EP0635004B1 (en) 2002-07-17
HUT70517A (en) 1995-10-30
NO981431L (no) 1994-12-09
JP2004285072A (ja) 2004-10-14
NO305077B1 (no) 1999-03-29
HU9402913D0 (en) 1995-01-30
NO981432L (no) 1994-12-09
EP0635004A1 (en) 1995-01-25
IL105328A0 (en) 1993-08-18
FI20002460A (fi) 2000-11-09
NO305023B1 (no) 1999-03-22
JP3686950B2 (ja) 2005-08-24
JP2005213268A (ja) 2005-08-11
PT635004E (pt) 2002-12-31
NO981433D0 (no) 1998-03-30
NO981432D0 (no) 1998-03-30
DK0635004T3 (da) 2002-11-11
JP4266184B2 (ja) 2009-05-20
AU3797393A (en) 1993-11-18
HU226561B1 (en) 2009-04-28
ES2176201T3 (es) 2002-12-01
NO981434L (no) 1994-12-09

Similar Documents

Publication Publication Date Title
FI106454B (fi) Menetelmä 4-[4-[4-(hydroksidifenyylimetyyli)-1-piperidinyyli]-1-hydroksibutyyli]- ja 4-[4-[4-(hydroksidifenyylimetyyli)-1-piperidinyyli]-1-oksobutyyli]johdannaisten valmistamiseksi
NO319850B1 (no) Fremgangsmater for fremstilling av verdifulle terapeutisk aktive piperidinderivater.
EP0703902B1 (en) Process for the production of piperidine derivatives
EP0877733B1 (en) Process for production of piperidine derivatives
AU723231B2 (en) Process for production of piperidine derivatives
US5644061A (en) Process for piperidine derivatives
US5654433A (en) Process for piperidine derivatives
US6054586A (en) Process for the preparation of 4-methylenepiperidine
EP1068180A1 (en) Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors
US20040077900A1 (en) Process for the preparation of a highly pure pharmaceutical intermediate, 4-(cyclopropylcarbonyl)-alpha, alpha-dimethylphenylacetic acid
EP1400511B1 (en) Methods of producing n-alkoxycarbonylpiperidine derivatives and intermediates therefor
JP2004131486A (ja) N−アルコキシカルボニルピペリジン誘導体の製造方法、並びにその原料化合物及びその製造方法
AU1742299A (en) Piperidine derivatives and process for their production

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AVENTIS INC.

Free format text: AVENTIS INC.

PC Transfer of assignment of patent

Owner name: AVENTISUB II INC.

Free format text: AVENTISUB II INC.

MA Patent expired